IL146131A0 - Treatment of neurotic disorders - Google Patents

Treatment of neurotic disorders

Info

Publication number: IL146131A0
Authority: IL; Israel
Prior art keywords: treatment; neurotic disorders; neurotic; disorders
Prior art date: 1999-07-08

Application number

IL14613100A

Other languages

English (en)

Original Assignee

Lundbeck & Co As H

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-07-08

Filing date

2000-07-07

Publication date

2002-07-25

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8099796&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL146131(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2000-07-07 Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H

2002-07-25 Publication of IL146131A0 publication Critical patent/IL146131A0/xx

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis

IL14613100A 1999-07-08 2000-07-07 Treatment of neurotic disorders IL146131A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DKPA199900991		1999-07-08
PCT/DK2000/000377 WO2001003694A1 (en)	1999-07-08	2000-07-07	Treatment of neurotic disorders

Publications (1)

Publication Number	Publication Date
IL146131A0 true IL146131A0 (en)	2002-07-25

Family

ID=8099796

Family Applications (5)

Application Number	Title	Priority Date	Filing Date
IL14613100A IL146131A0 (en)	1999-07-08	2000-07-07	Treatment of neurotic disorders
IL146131A IL146131A (en)	1999-07-08	2001-10-23	Pharmacological compositions containing acetylsalone for the treatment of neurotic disorders
IL170192A IL170192A (en)	1999-07-08	2005-08-09	Medicament for treatment of neurotic disorders
IL170194A IL170194A (en)	1999-07-08	2005-08-09	Medicament for treatment of neurotic disorders
IL170193A IL170193A (en)	1999-07-08	2005-08-09	Medicament for treatment of neurotic disorders

Family Applications After (4)

Application Number	Title	Priority Date	Filing Date
IL146131A IL146131A (en)	1999-07-08	2001-10-23	Pharmacological compositions containing acetylsalone for the treatment of neurotic disorders
IL170192A IL170192A (en)	1999-07-08	2005-08-09	Medicament for treatment of neurotic disorders
IL170194A IL170194A (en)	1999-07-08	2005-08-09	Medicament for treatment of neurotic disorders
IL170193A IL170193A (en)	1999-07-08	2005-08-09	Medicament for treatment of neurotic disorders

Country Status (38)

Country	Link
US (6)	US7271194B2 (xx)
EP (4)	EP1440691A3 (xx)
JP (1)	JP4773011B2 (xx)
KR (1)	KR100604176B1 (xx)
CN (1)	CN1198610C (xx)
AR (1)	AR021155A1 (xx)
AT (1)	ATE339955T1 (xx)
AU (6)	AU782514B2 (xx)
BG (4)	BG110466A (xx)
BR (1)	BR0011578A (xx)
CA (4)	CA2687392A1 (xx)
CL (3)	CL2008003938A1 (xx)
CO (1)	CO5190674A1 (xx)
CY (1)	CY1105806T1 (xx)
CZ (1)	CZ200270A3 (xx)
DE (1)	DE60030861T2 (xx)
DK (1)	DK1200081T3 (xx)
EA (1)	EA006555B1 (xx)
ES (1)	ES2272298T3 (xx)
HK (1)	HK1048069B (xx)
HR (1)	HRP20010820A2 (xx)
HU (1)	HUP0201791A3 (xx)
IL (5)	IL146131A0 (xx)
IS (1)	IS6137A (xx)
ME (2)	ME00032B (xx)
MX (1)	MXPA01011626A (xx)
MY (1)	MY143278A (xx)
NO (4)	NO329021B1 (xx)
PL (1)	PL352030A1 (xx)
PT (1)	PT1200081E (xx)
SI (1)	SI1200081T1 (xx)
SK (1)	SK82002A3 (xx)
TR (4)	TR200402276T2 (xx)
TW (1)	TWI232101B (xx)
UA (1)	UA77645C2 (xx)
WO (1)	WO2001003694A1 (xx)
YU (1)	YU78701A (xx)
ZA (1)	ZA200108856B (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR021155A1 (es)	1999-07-08	2002-06-12	Lundbeck & Co As H	Tratamiento de desordenes neuroticos
GB0005477D0 (en)	2000-03-07	2000-04-26	Resolution Chemicals Limited	Process for the preparation of citalopram
IL153988A0 (en)	2000-07-21	2003-07-31	Lundbeck & Co As H	Novel compounds and their use as glycine transport inhibitors
KR20040030609A (ko) *	2001-05-01	2004-04-09	하. 룬트벡 아크티에 셀스카브	경상이성체성 순수 에스시탈로프람의 용도
EP1414435B1 (en)	2001-07-31	2005-01-12	H. Lundbeck A/S	Crystalline composition containing escitalopram
AU2003237524A1 (en) *	2002-07-08	2004-01-23	University Of Florida	Use of ssri inhibitors to prevent or ameliorate trauma-related psychological disorders
DE60319739T2 (de) *	2002-12-23	2008-07-17	H. Lundbeck A/S, Valby	Escitalopramhydrobromid und ein verfahren zu dessen herstellung
US20050137255A1 (en) *	2002-12-23	2005-06-23	H. Lundbeck A/S	Crystalline escitalopram hydrobromide and methods for preparing the same
TR200504022T1 (tr) *	2003-03-24	2006-08-21	Hetero Drugs Limited	(S)-sitalopram oksalatın yeni sıvı kristal formları.
US20090093461A1 (en) *	2003-07-02	2009-04-09	Astrazeneca Ab	Methods of Treating Anxiety and Mood Disorders
US7884096B2 (en) *	2003-12-02	2011-02-08	Pharmaneuroboost N.V.	Method of treating mental disorders using of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
EP2272514A1 (en) *	2003-12-02	2011-01-12	PharmaNeuroBoost N.V.	Use of low dose pipamperone and a second active compound in the treatment of neurodegenerative diseases
US7855195B2 (en) *	2003-12-02	2010-12-21	Pharmaneuroboost N.V.	Method of treating mental disorders using D4 and 5-HT2A antagonists, inverse agonists or partial agonists
BRPI0617382A2 (pt)	2005-10-14	2017-07-11	H Lundbeck As	Métodos para tratar um distúrbio do sistema nervoso central em um paciente, para tratar um paciente sofrendo de condições e uma disfunção sexual, e para reduzir um retardo na eficácia terapêutica em seguida ao início do tratamento
US20070134322A1 (en) *	2005-12-14	2007-06-14	Forest Laboratories, Inc.	Modified and pulsatile release pharmaceutical formulations of escitalopram
FR2912057B1 (fr) *	2007-02-07	2009-04-17	Sanofi Aventis Sa	Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine
TW200817003A (en) *	2006-07-31	2008-04-16	Sanofi Aventis	Pharmaceutical composition comprising, in combination, saredutant and a selective serotonin peuptake inhibitor or a serotonin/norepinephrine reuptake inhibitor

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1143703A (xx) *	1965-03-18
GB1526331A (en) *	1976-01-14	1978-09-27	Kefalas As	Phthalanes
US4439545A (en)	1981-11-19	1984-03-27	Societe D "Expansion Scientifique "Expansia"	Acrylic copolymers of N-acryloylpolymethyleneimines or N-acryloyldialkylamides, N,N'-acryloyldiaminoalcanes and N-acryloylaminoacids (or esters) their preparation and use as cation exchangers
GB8419963D0 (en) *	1984-08-06	1984-09-12	Lundbeck & Co As H	Intermediate compound and method
GB8607313D0 (en) *	1986-03-25	1986-04-30	Ici Plc	Pharmaceutical compositions
GB8814057D0 (en)	1988-06-14	1988-07-20	Lundbeck & Co As H	New enantiomers & their isolation
US4902710A (en) *	1988-12-14	1990-02-20	Eli Lilly And Company	Serotonin and norepinephrine uptake inhibitors
US5114976A (en) *	1989-01-06	1992-05-19	Norden Michael J	Method for treating certain psychiatric disorders and certain psychiatric symptoms
US4962128A (en) *	1989-11-02	1990-10-09	Pfizer Inc.	Method of treating anxiety-related disorders using sertraline
US5296507A (en) *	1990-09-06	1994-03-22	H.Lundbeck A/S	Treatment of cerbrovascular disorders
DK213290D0 (da) *	1990-09-06	1990-09-06	Lundbeck & Co As H	Treatment of cerebrovascular disorders
US5708035A (en) *	1991-02-04	1998-01-13	Sepracor Inc.	Methods of use and compositions of R(-) fluoxetine
WO1992018005A1 (en)	1991-04-16	1992-10-29	National Institutes Of Health	Method of treating trichotillomania and onychophagia
DE69233124T2 (de)	1991-11-15	2004-02-19	Sepracor Inc., Marlborough	Verwendung von reinem fluoxetin-s(+)-isomer für die herstellung eines medikements gegen migräne
EP0714663A3 (en)	1994-11-28	1997-01-15	Lilly Co Eli	Potentiation of drug responses by serotonin 1A receptor antagonists
US5627196A (en) *	1995-01-17	1997-05-06	Eli Lilly And Company	Compounds having effects on serotonin-related systems
AU4918796A (en) *	1995-02-10	1996-08-27	Eli Lilly And Company	Methods of treating or preventing psychiatric disorders
US5554383A (en) *	1995-04-06	1996-09-10	Trustees Of Tufts College	Veterinary method for clinically modifying the behavior of dogs exhibiting canine affective aggression
SE9501567D0 (sv) *	1995-04-27	1995-04-27	Astra Ab	A new combination
AU6776196A (en)	1995-08-16	1997-03-12	Eli Lilly And Company	Potentiation of serotonin response
US5846982A (en) *	1996-06-14	1998-12-08	Eli Lilly And Company	Inhibition of serotonin reuptake
US5912256A (en) *	1996-06-20	1999-06-15	Eli Lilly And Company	Compounds having effects on serotonin-related systems
US5747494A (en) *	1996-06-28	1998-05-05	U C B S.A.	Pharmaceutical compositions for the treatment of depressive disorders
US5958429A (en) *	1996-08-16	1999-09-28	Eli Lilly And Company	Potentiation of serotonin response
ZA977967B (en) *	1996-09-23	1999-03-04	Lilly Co Eli	Combination therapy for treatment of psychoses
US5776969A (en) *	1997-02-27	1998-07-07	Eli Lilly And Company	Treatment of sleep disorders
US6069177A (en) *	1997-07-08	2000-05-30	The Hong Kong University Of Science And Technology	3-Hydroxy-propanamine derived neuronal reuptake inhibitors
SE9703379D0 (sv) *	1997-09-18	1997-09-18	Astra Ab	New compounds
SE9703375D0 (sv) *	1997-09-18	1997-09-18	Astra Ab	A new combination
EP1042310B1 (en) *	1997-11-11	2002-07-31	H. Lundbeck A/S	Method for the preparation of citalopram
DE69903992T2 (de) *	1998-04-15	2003-08-21	Pfizer Prod Inc	Heterocyclische Carboxamide
EP1100501A4 (en) *	1998-06-30	2002-12-04	Lilly Co Eli	PYRROLIDINE AND PYRROLIDINE DERIVATIVES INFLUENTING THE SYSTEMS ASSOCIATED WITH SEROTONIN
AU771252B2 (en)	1998-07-13	2004-03-18	Nps Pharmaceuticals, Inc.	Methods and compounds for treating depression and other disorders
US6579899B1 (en)	1998-07-16	2003-06-17	Massachusetts Institute Of Technology	Composition for treatment of stress
CA2337507A1 (en)	1998-07-16	2000-01-27	Massachusetts Institute Of Technology	Composition for treatment of stress
US6150376A (en) *	1998-08-05	2000-11-21	Georgetown University	Bi- and tri-cyclic aza compounds and their uses
SE9803157D0 (sv)	1998-09-16	1998-09-16	Astra Ab	A new composition
SE9803158D0 (sv) *	1998-09-16	1998-09-16	Astra Ab	A new composition
ES2189502T3 (es) *	1998-10-20	2003-07-01	Lundbeck & Co As H	Metodo para la prevencion de citalopram.
AR021509A1 (es) *	1998-12-08	2002-07-24	Lundbeck & Co As H	Derivados de benzofurano, su preparacion y uso
PT1173431E (pt) *	1999-04-14	2003-09-30	Lundbeck & Co As H	Metodo de preparacao do citalopram
AR021155A1 (es) *	1999-07-08	2002-06-12	Lundbeck & Co As H	Tratamiento de desordenes neuroticos
US6333357B1 (en) *	1999-11-05	2001-12-25	Be Able, Llc	Behavior chemotherapy
UA77650C2 (en) *	1999-12-06	2007-01-15	Lundbeck & Co As H	Use of serotonin reuptake inhibitor in combination with deramcyclane
GB2357762B (en) *	2000-03-13	2002-01-30	Lundbeck & Co As H	Crystalline base of citalopram
JP2003531169A (ja) *	2000-04-24	2003-10-21	アリックスセラピューティクス	うつ病治療のための材料と方法
JP2002361405A (ja) *	2000-09-25	2002-12-18	Showa Denko Kk	熱交換器の製造方法
KR20040030609A (ko) *	2001-05-01	2004-04-09	하. 룬트벡 아크티에 셀스카브	경상이성체성 순수 에스시탈로프람의 용도

2000
- 2000-07-06 AR ARP000103442A patent/AR021155A1/es unknown
- 2000-07-07 ME MEP-2008-25A patent/ME00032B/me unknown
- 2000-07-07 AT AT00943692T patent/ATE339955T1/de active
- 2000-07-07 CO CO00051031A patent/CO5190674A1/es not_active Application Discontinuation
- 2000-07-07 EP EP04007522A patent/EP1440691A3/en not_active Withdrawn
- 2000-07-07 JP JP2001508974A patent/JP4773011B2/ja not_active Expired - Lifetime
- 2000-07-07 WO PCT/DK2000/000377 patent/WO2001003694A1/en active Application Filing
- 2000-07-07 MY MYPI20003122A patent/MY143278A/en unknown
- 2000-07-07 MX MXPA01011626A patent/MXPA01011626A/es not_active Application Discontinuation
- 2000-07-07 EA EA200200137A patent/EA006555B1/ru not_active IP Right Cessation
- 2000-07-07 PL PL00352030A patent/PL352030A1/xx not_active Application Discontinuation
- 2000-07-07 KR KR1020017016006A patent/KR100604176B1/ko not_active IP Right Cessation
- 2000-07-07 SI SI200030910T patent/SI1200081T1/sl unknown
- 2000-07-07 CA CA2687392A patent/CA2687392A1/en not_active Abandoned
- 2000-07-07 TR TR2004/02276T patent/TR200402276T2/xx unknown
- 2000-07-07 PT PT00943692T patent/PT1200081E/pt unknown
- 2000-07-07 TR TR2004/02275T patent/TR200402275T2/xx unknown
- 2000-07-07 TR TR2004/02277T patent/TR200402277T2/xx unknown
- 2000-07-07 EP EP04007520A patent/EP1440689A3/en not_active Withdrawn
- 2000-07-07 ES ES00943692T patent/ES2272298T3/es not_active Expired - Lifetime
- 2000-07-07 BR BR0011578-9A patent/BR0011578A/pt active Search and Examination
- 2000-07-07 EP EP00943692A patent/EP1200081B1/en not_active Revoked
- 2000-07-07 AU AU58061/00A patent/AU782514B2/en not_active Expired
- 2000-07-07 CA CA002373757A patent/CA2373757C/en not_active Expired - Lifetime
- 2000-07-07 HU HU0201791A patent/HUP0201791A3/hu unknown
- 2000-07-07 ME MEP-25/08A patent/MEP2508A/xx unknown
- 2000-07-07 EP EP04007521A patent/EP1440690A3/en not_active Withdrawn
- 2000-07-07 TR TR2002/00014T patent/TR200200014T2/xx unknown
- 2000-07-07 CA CA2687396A patent/CA2687396A1/en not_active Abandoned
- 2000-07-07 SK SK8-2002A patent/SK82002A3/sk not_active Application Discontinuation
- 2000-07-07 UA UA2001128286A patent/UA77645C2/uk unknown
- 2000-07-07 CN CNB008100292A patent/CN1198610C/zh not_active Expired - Lifetime
- 2000-07-07 IL IL14613100A patent/IL146131A0/xx unknown
- 2000-07-07 DE DE60030861T patent/DE60030861T2/de not_active Expired - Lifetime
- 2000-07-07 DK DK00943692T patent/DK1200081T3/da active
- 2000-07-07 CZ CZ200270A patent/CZ200270A3/cs unknown
- 2000-07-07 CA CA2687394A patent/CA2687394A1/en not_active Abandoned
- 2000-07-07 YU YU78701A patent/YU78701A/sh unknown
- 2000-07-28 TW TW089115110A patent/TWI232101B/zh not_active IP Right Cessation
2001
- 2001-10-23 IL IL146131A patent/IL146131A/en active IP Right Grant
- 2001-10-26 ZA ZA200108856A patent/ZA200108856B/xx unknown
- 2001-10-30 IS IS6137A patent/IS6137A/is unknown
- 2001-11-06 HR HR20010820A patent/HRP20010820A2/hr not_active Application Discontinuation
- 2001-12-12 US US10/021,126 patent/US7271194B2/en not_active Expired - Lifetime
2002
- 2002-01-04 BG BG11046609A patent/BG110466A/bg unknown
- 2002-01-04 BG BG11046809A patent/BG110468A/bg unknown
- 2002-01-04 BG BG11046709A patent/BG110467A/bg unknown
- 2002-01-04 BG BG106279A patent/BG106279A/bg unknown
- 2002-01-07 NO NO20020062A patent/NO329021B1/no not_active IP Right Cessation
2003
- 2003-01-09 HK HK03100231.6A patent/HK1048069B/zh not_active IP Right Cessation
- 2003-08-07 US US10/637,822 patent/US20040029958A1/en not_active Abandoned
- 2003-08-07 US US10/637,820 patent/US7265151B2/en not_active Expired - Lifetime
- 2003-08-07 US US10/637,821 patent/US20040029957A1/en not_active Abandoned
- 2003-08-20 US US10/644,143 patent/US6960613B2/en not_active Expired - Lifetime
2005
- 2005-06-20 AU AU2005202685A patent/AU2005202685B2/en not_active Ceased
- 2005-06-20 AU AU2005202686A patent/AU2005202686B2/en not_active Expired
- 2005-06-20 AU AU2005202684A patent/AU2005202684B2/en not_active Ceased
- 2005-08-09 IL IL170192A patent/IL170192A/en unknown
- 2005-08-09 IL IL170194A patent/IL170194A/en unknown
- 2005-08-09 IL IL170193A patent/IL170193A/en unknown
2006
- 2006-11-27 CY CY20061101706T patent/CY1105806T1/el unknown
2007
- 2007-08-10 US US11/837,317 patent/US20070276035A1/en not_active Abandoned
2008
- 2008-12-24 AU AU2008264182A patent/AU2008264182A1/en not_active Withdrawn
- 2008-12-24 AU AU2008264188A patent/AU2008264188A1/en not_active Withdrawn
- 2008-12-30 CL CL2008003938A patent/CL2008003938A1/es unknown
- 2008-12-30 CL CL2008003939A patent/CL2008003939A1/es unknown
- 2008-12-30 CL CL2008003941A patent/CL2008003941A1/es unknown
2010
- 2010-03-10 NO NO20100335A patent/NO20100335L/no not_active Application Discontinuation
- 2010-03-10 NO NO20100334A patent/NO20100334L/no not_active Application Discontinuation
- 2010-03-10 NO NO20100333A patent/NO20100333L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
KR20020015346A (ko)	2002-02-27
TR200402277T2 (tr)	2005-01-24
TR200200014T2 (tr)	2002-05-21
CL2008003939A1 (es)	2009-06-05
PL352030A1 (en)	2003-07-28
EA200200137A1 (ru)	2002-06-27
CN1198610C (zh)	2005-04-27
EP1200081A1 (en)	2002-05-02
CN1360501A (zh)	2002-07-24
BR0011578A (pt)	2002-03-26
DE60030861D1 (de)	2006-11-02
CZ200270A3 (cs)	2002-04-17
NO329021B1 (no)	2010-07-26
PT1200081E (pt)	2007-01-31
AU782514B2 (en)	2005-08-04
SK82002A3 (en)	2002-07-02
NO20100334L (no)	2002-01-07
NO20100333L (no)	2002-01-07
MY143278A (en)	2011-04-15
BG110468A (en)	2010-01-29
CA2687394A1 (en)	2001-01-18
MXPA01011626A (es)	2002-06-04
IL146131A (en)	2007-02-11
BG106279A (bg)	2002-08-30
NO20020062D0 (no)	2002-01-07
TWI232101B (en)	2005-05-11
EA006555B1 (ru)	2006-02-24
CY1105806T1 (el)	2011-02-02
CA2687392A1 (en)	2001-01-18
EP1440690A3 (en)	2004-08-18
AU5806100A (en)	2001-01-30
NO20100335L (no)	2002-01-07
US20070276035A1 (en)	2007-11-29
AU2005202686B2 (en)	2009-01-15
IS6137A (is)	2001-10-30
ZA200108856B (en)	2002-12-24
ATE339955T1 (de)	2006-10-15
BG110466A (en)	2010-01-29
WO2001003694A1 (en)	2001-01-18
US20040029958A1 (en)	2004-02-12
IL170192A (en)	2010-04-29
HRP20010820A2 (en)	2003-08-31
US7265151B2 (en)	2007-09-04
US20040029957A1 (en)	2004-02-12
JP4773011B2 (ja)	2011-09-14
AU2005202686A1 (en)	2005-07-14
ES2272298T3 (es)	2007-05-01
HK1048069B (zh)	2005-12-16
US20050101665A1 (en)	2005-05-12
TR200402275T2 (tr)	2005-03-21
US20020086899A1 (en)	2002-07-04
AU2005202685B2 (en)	2009-01-15
EP1440691A2 (en)	2004-07-28
DK1200081T3 (da)	2006-12-27
CA2373757A1 (en)	2001-01-18
UA77645C2 (en)	2007-01-15
IL170193A (en)	2010-04-29
US20040029956A1 (en)	2004-02-12
KR100604176B1 (ko)	2006-07-25
BG110467A (en)	2010-01-29
AU2005202685A1 (en)	2005-07-14
CO5190674A1 (es)	2002-08-29
AU2005202684A1 (en)	2005-07-14
JP2003504332A (ja)	2003-02-04
TR200402276T2 (tr)	2005-01-24
EP1440689A3 (en)	2004-08-25
DE60030861T2 (de)	2007-05-03
HK1048069A1 (en)	2003-03-21
MEP2508A (xx)	2010-02-10
AU2005202684B2 (en)	2009-01-15
IL170194A (en)	2010-05-31
EP1200081B1 (en)	2006-09-20
YU78701A (sh)	2004-03-12
AU2008264188A1 (en)	2009-05-07
US6960613B2 (en)	2005-11-01
EP1440690A2 (en)	2004-07-28
AR021155A1 (es)	2002-06-12
NO20020062L (no)	2002-01-07
SI1200081T1 (sl)	2007-02-28
CL2008003941A1 (es)	2009-05-22
EP1440689A2 (en)	2004-07-28
AU2008264182A1 (en)	2009-01-29
CA2373757C (en)	2010-01-05
HUP0201791A3 (en)	2005-02-28
ME00032B (me)	2010-02-10
US7271194B2 (en)	2007-09-18
CA2687396A1 (en)	2001-01-18
EP1440691A3 (en)	2004-08-25
CL2008003938A1 (es)	2009-05-22
HUP0201791A2 (en)	2002-10-28

Publication	Publication Date	Title
GB0007193D0 (en)	2000-05-17	Treatment of movrmrnt disorders
HUP0400914A3 (en)	2007-05-29	Methods of treatment of mitochondrial disorders
EP1063990A4 (en)	2003-01-02	THERAPY FOR ESTROGEN RELATED DISORDERS
IL146131A0 (en)	2002-07-25	Treatment of neurotic disorders
EP1239851A4 (en)	2005-09-14	TREATMENT OF HYPERPROLIFERATIVE DISORDERS
EP1126850A4 (en)	2003-01-15	TREATMENT OF CONDITIONS OF THE RETINA
GB9926968D0 (en)	2000-01-12	Treatment of neurological disorders
AU7106300A (en)	2001-04-10	Treatment of skin disorders
GB2360453B (en)	2004-09-01	Treatment of skin conditions
HUP0102886A2 (en)	2002-06-29	Treatment of anxiety disorders
IL131347A0 (en)	2001-03-19	Treatment of skin disorders
AR026062A1 (es)	2002-12-26	Tratamiento de desordenes oculares
GB0101146D0 (en)	2001-02-28	Treatment of skin conditions
GB9924942D0 (en)	1999-12-22	Treatment of movement disorders
IL153788A0 (en)	2003-07-31	Treatment of eating disorders using carboxyalkylethers
GB9815188D0 (en)	1998-09-09	Treatment of skin disorders
GB0017951D0 (en)	2000-09-13	Treatment of movement disorders
GB0024704D0 (en)	2000-11-22	Treatment of hyperproliferative skin disorders
GB9923551D0 (en)	1999-12-08	Treatment of neuropsychiatric disorders
AU2004235661B2 (en)	2007-03-01	Methods of treatment of mitochondrial disorders
GB9914103D0 (en)	1999-08-18	Treatment of oils
GB9914106D0 (en)	1999-08-18	Treatment of oils
GB9914101D0 (en)	1999-08-18	Treatment of oils
GB9727001D0 (en)	1998-02-18	Treatment of movement disorders
GB0003228D0 (en)	2000-04-05	Treatment of GI disorders